Immunotherapy drug nivolumab takes on rare childhood and adult lymphoma
NCT ID NCT03703050
First seen Apr 24, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study tests the immunotherapy drug nivolumab in children and adults with a rare type of lymphoma (ALK+ anaplastic large cell lymphoma) that has come back or not responded to standard treatment. The trial has two groups: one for people with active disease to see if the drug shrinks tumors, and another for those already in remission after a relapse to see if it helps keep the cancer away. About 45 participants will receive nivolumab alone, and the goal is to measure how well the cancer responds or how long it stays gone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING/REFRACTORY ALK+ ANAPLASTIC LARGE CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Bordeaux
Bordeaux, France
-
CHU Bordeaux Hopital Pellegrin
Bordeaux, 33076, France
-
CHU Mondor
Créteil, France
-
CHU Toulouse Hopital des enfants
Toulouse, 31059, France
-
CHU de nancy
Vandœuvre-lès-Nancy, 54500, France
-
Centre Léon Berard Lyon
Lyon, 69008, France
-
Centre Oscar Lambret
Lille, France
-
Gustave Roussy
Villejuif, Val de Marne, 94805, France
-
Hôpital Saint Louis
Paris, 75010, France
-
Hôpital Trousseau
Paris, Paris, 75012, France
-
IUC Toulouse
Toulouse, 31059, France
-
Rigshospitalet
Copenhagen, Denmark
-
Women'S and Children'S Nhs Foundation Trust
Birmingham, United Kingdom
Conditions
Explore the condition pages connected to this study.